Notable Put Options Activity in Cytori Therapeutics

Shares of Cytori Therapeutics

are lower on the session by 7.85%, currently trading at $2.70. The stock has been moving largely lower over the past six weeks and is currently trading below the 50-day moving average. Options traders are focusing on puts today. The strike seeing the heaviest action is the April 2012 $2.50 put, which has traded 1,000 times on open interest of 77 contracts. Put volume is outpacing call volume by 32 to 1. Cytori Therapeutics, Inc. develops, manufactures, and sells medical products and devices to enable the practice of regenerative medicine. The company's technology is the Celuion family of products, which processes patients' adipose-derived stem and regenerative cells at the point of care.